We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BOI market cap is 460.08M. The company's latest EPS is EUR 2.0636 and P/E is 12.84.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 558.75M | 514.85M | 457.31M | 537.1M | 495.13M |
| Operating Income | 83.02M | 150.72M | 38.25M | 54.23M | 43.28M |
| Net Income | 40.63M | 26.21M | 28.56M | 44.67M | 35.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 764.28M | 781.82M | 770.7M | 789.49M | 590.2M |
| Total Liabilities | 258.82M | 272.65M | 238.93M | 232.15M | 198.7M |
| Total Equity | 505.46M | 509.17M | 531.77M | 557.35M | 391.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 50.86M | 68.27M | 33.32M | 58.69M | 45.49M |
| Investing | -33.56M | -19.34M | -11.92M | -15.28M | -22.93M |
| Financing | -27.19M | -21.52M | -22M | -27.58M | -198.41M |
| Market Cap | 460.08M |
| Price to Earnings Ratio | 12.84 |
| Price to Sales Ratio | 0.93 |
| Price to Cash Ratio | 6.21 |
| Price to Book Ratio | 1.18 |
| Dividend Yield | 5.09% |
| Shares Outstanding | 17.36M |
| Average Volume (1 week) | 1.62k |
| Average Volume (1 Month) | 2.54k |
| 52 Week Change | -34.24% |
| 52 Week High | 42.80 |
| 52 Week Low | 26.30 |
| Spread (Intraday) | 0.55 (2.04%) |
| Company Name | Boiron |
| Address |
2, avenue de l’ouest lyonnais lyon, rhone 69510 |
| Website | https://www.boiron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
